相关实验视频
Updated: May 17, 2025

12:08
Improving IV Insulin Administration in a Community Hospital
Published on: June 11, 2012
18.5K
对-葡萄糖辅运输体2抑制剂的洞察性观点:导航安全更新和超越
Pratikeswar Panda1, Rajaram Mohapatra1, Biswajit Samantaray1
1Department of Pharmaceutics, School of Pharmaceutical Science, Siksha 'O' Anusandhan University, Bhubaneswar, Odisha, India.
Current drug research reviews
|April 4, 2025
概括
-葡萄糖辅运输体2 (SGLT2) 抑制剂是有效的2型糖尿病治疗方法,具有心血管和脏的好处. 虽然通常是安全的,但潜在的风险,如低血糖和感染,需要仔细监测患者.
科学领域:
- 内分泌学 在内分泌学.
- 腎臟病學 (nephrology) 是一種醫學.
- 心脏病学 心脏病学
背景情况:
- -葡萄糖辅运输体2 (SGLT2) 抑制剂代表了用于2型糖尿病管理的新型口服药物类别.
- 这些 Gliflozin 向SGLT2 在附近的管中,减少葡萄糖和的再吸收,并促进尿中的糖分泌.
- 除了血糖控制之外,SGLT2抑制剂表现出对心脏和功能有益的类作用.
研究的目的:
- 提供目前可用的SGLT2抑制剂的全面安全概述.
- 总结一下与这种类型糖尿病药物相关的已知风险和益处.
主要方法:
- 对SGLT2抑制剂的安全数据的文献综述.
- 分析报告的不良事件和临床试验结果.
主要成果:
- SGLT2 抑制剂显示出显著的心血管和脏保护作用.
- 潜在的不良事件包括低血糖症,尿路感染,糖尿病酸性脂肪酸症,下肢截肢和骨折.
- 虽然有些风险并不常见,但它们可能会产生严重的后果,需要密切监督患者.
结论:
- SGLT2抑制剂是2型糖尿病的有效治疗方法,提供了相当大的心血管和脏保护.
- 整体安全性概况有利,但对特定不良事件的仔细监测对于患者安全至关重要.
相关概念视频
Glucose Transporters
22.3K
Glucose transporters facilitate the transport of glucose across the cell membrane. In addition to glucose, some glucose transporters can also aid the movement of other hexoses such as fructose, mannose, and galactose.
Facilitated diffusion-glucose transporters (GLUTs) are encoded by the solute-linked carrier (SLC) family 2, subfamily A gene family, or SLC2A. The 14 GLUT protein members are distributed into three classes:
Facilitated diffusion-glucose transporters (GLUTs) are encoded by the solute-linked carrier (SLC) family 2, subfamily A gene family, or SLC2A. The 14 GLUT protein members are distributed into three classes:
22.3K
Oral Hypoglycemic Agents: Biguanides and Glitazones
144
Biguanides, particularly metformin (Glucophage), are insulin sensitizers that enhance glucose uptake, thereby reducing insulin resistance. Unlike sulfonylureas, metformin doesn't prompt insulin secretion, which helps to curb hypoglycemia risk. Metformin is beneficial in treating conditions like polycystic ovary syndrome due to its insulin-resistance reduction capability. The drug's primary action involves curtailing hepatic gluconeogenesis, a significant contributor to high blood...
144
Oral Hypoglycemic Agents: Glinides
114
Repaglinide (Prandin) and Nateglinide (Starlix), known as glinides, are oral insulin secretagogues that stimulate insulin release from pancreatic β cells by closing the ATP-sensitive potassium channels (KATP channel). Repaglinide controls insulin release from pancreatic β cells by managing potassium efflux. It shares two binding sites with sulfonylureas and also has a unique site, indicating overlapping mechanisms of action. With a rapid onset and a 4-7 hour duration, it effectively...
114
Oral Hypoglycemic Agents: Sulfonylureas
167
Sulfonylureas are oral hypoglycemic agents utilized in treating type 2 diabetes. They are characterized by their unique sulfonylurea chemical structure. The family of sulfonylureas is divided into generations. First-generation sulfonylureas, including tolbutamide (Orinase), chlorpropamide (Diabinese), and tolazamide (Tolinase), trigger insulin release from pancreatic β cells and enhance peripheral tissues' insulin sensitivity. The second-generation members, such as glipizide...
167
Secondary Active Transport
6.6K
One example of how cells use the energy contained in electrochemical gradients is demonstrated by glucose transport into cells. The ion vital to this process is sodium (Na+), which is typically present in higher concentrations extracellularly than in the cytosol. Such a concentration difference is due, in part, to the action of an enzyme "pump" embedded in the cellular membrane that actively expels Na+ from a cell. Importantly, as this pump contributes to the high concentration of...
6.6K
Oral Hypoglycemic Agents: α-Glucosidase Inhibitors
130
α-glucosidase inhibitors, including acarbose (Precose), miglitol (Glyset), and voglibose (Voglib) (primarily available in Asia), are drugs that control blood sugar levels by delaying the digestion of starch and disaccharides. They achieve this by inhibiting α-glucosidase enzymes in the intestine, which slow the absorption of carbohydrates in the intestine, which in turn leads to a prolonged release of the glucoregulatory hormone GLP-1 from intestinal L-cells.
Acarbose and miglitol are...
Acarbose and miglitol are...
130

